ES2093905T3 - Nuevo procedimiento para la obtencion de derivados de la n4-acil-5'-desoxi-5-fluorocitidina. - Google Patents

Nuevo procedimiento para la obtencion de derivados de la n4-acil-5'-desoxi-5-fluorocitidina.

Info

Publication number
ES2093905T3
ES2093905T3 ES93119528T ES93119528T ES2093905T3 ES 2093905 T3 ES2093905 T3 ES 2093905T3 ES 93119528 T ES93119528 T ES 93119528T ES 93119528 T ES93119528 T ES 93119528T ES 2093905 T3 ES2093905 T3 ES 2093905T3
Authority
ES
Spain
Prior art keywords
acil
fluorocitidine
deoxi
derivatives
desoxi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93119528T
Other languages
English (en)
Spanish (es)
Inventor
Takashi Kamiya
Makoto Ishiduka
Hiroshi Nakajima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Fuji Chemical Industries Co Ltd
Original Assignee
F Hoffmann La Roche AG
Fuji Chemical Industries Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG, Fuji Chemical Industries Co Ltd filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2093905T3 publication Critical patent/ES2093905T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ES93119528T 1992-12-18 1993-12-03 Nuevo procedimiento para la obtencion de derivados de la n4-acil-5'-desoxi-5-fluorocitidina. Expired - Lifetime ES2093905T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92121539 1992-12-18

Publications (1)

Publication Number Publication Date
ES2093905T3 true ES2093905T3 (es) 1997-01-01

Family

ID=8210305

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93119528T Expired - Lifetime ES2093905T3 (es) 1992-12-18 1993-12-03 Nuevo procedimiento para la obtencion de derivados de la n4-acil-5'-desoxi-5-fluorocitidina.

Country Status (13)

Country Link
US (1) US5453497A (cg-RX-API-DMAC10.html)
EP (1) EP0602478B1 (cg-RX-API-DMAC10.html)
JP (2) JP3530218B2 (cg-RX-API-DMAC10.html)
KR (1) KR100343481B1 (cg-RX-API-DMAC10.html)
CN (1) CN1035675C (cg-RX-API-DMAC10.html)
AT (1) ATE140923T1 (cg-RX-API-DMAC10.html)
CA (1) CA2110335C (cg-RX-API-DMAC10.html)
CY (1) CY2154B1 (cg-RX-API-DMAC10.html)
DE (1) DE69303879T2 (cg-RX-API-DMAC10.html)
DK (1) DK0602478T3 (cg-RX-API-DMAC10.html)
ES (1) ES2093905T3 (cg-RX-API-DMAC10.html)
RU (1) RU2131879C1 (cg-RX-API-DMAC10.html)
TW (1) TW254946B (cg-RX-API-DMAC10.html)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5476932A (en) * 1994-08-26 1995-12-19 Hoffmann-La Roche Inc. Process for producing N4-acyl-5'-deoxy-5-fluorocytidine derivatives
NZ330360A (en) * 1997-06-02 1999-03-29 Hoffmann La Roche 5'-deoxy-cytidine derivatives, their manufacture and use as antitumoral agents
EP0882734B1 (en) * 1997-06-02 2009-08-26 F. Hoffmann-La Roche Ag 5'-Deoxy-cytidine derivatives
US6005098A (en) * 1998-02-06 1999-12-21 Hoffmann-La Roche Inc. 5'deoxycytidine derivatives
KR100631754B1 (ko) * 2000-08-09 2006-10-09 주식회사 코오롱 Ｎ-알킬옥시카르보닐-5-플루오로사이토신 유도체 및 그의제조방법
EP1569652A4 (en) * 2001-12-14 2008-07-02 Pharmasset Inc NUCLEOSIDES N SP 4 / SP-ACYLCYTOSINES FOR THE TREATMENT OF VIRAL INFECTIONS
WO2004065403A1 (ja) * 2003-01-17 2004-08-05 Ajinomoto Co., Inc. ヌクレオシド化合物の製造方法
DE602004015331D1 (de) * 2003-12-22 2008-09-04 Hoffmann La Roche Verfahren für fluorcytidinderivate
CN100383128C (zh) * 2004-02-23 2008-04-23 上海迪赛诺医药发展有限公司 N4－氧羰基胞嘧啶衍生物及制备方法与应用
US20050192433A1 (en) * 2004-02-26 2005-09-01 Mitsui Chemicals, Inc. Metallic salt of N4-acylcytidine derivatives, and a method for producing N4-acylcytidine derivatives using the same
JP4627625B2 (ja) * 2004-03-11 2011-02-09 三井化学株式会社 Ｎ−アセチルシチジン類の製造方法
WO2006040645A1 (en) * 2004-10-11 2006-04-20 Ranbaxy Laboratories Limited N-(3,5-dichloropyridin-4-yl)-2,4,5-alkoxy and 2,3,4-alkoxy benzamide derivatives as pde-iv (phophodiesterase type-iv) inhibitors for the treatment of inflammatory diseases such as asthma
BRPI0606839B8 (pt) 2005-02-03 2021-12-14 Massachusetts Gen Hospital Uso de uma composição farmacêutica compreendendo um inibidor irreversível de receptor de fator de crescimento epidérmico (egfr)
WO2006103187A2 (en) * 2005-04-01 2006-10-05 F. Hoffmann-La Roche Ag Method for administration of capecitabine
RU2451524C2 (ru) 2005-11-04 2012-05-27 Вайет Противоопухолевые комбинации с ингибиторами mtor, герцептином и/или hki-272
US20080085310A1 (en) * 2006-10-06 2008-04-10 Maria Oksana Bachynsky Capecitabine rapidly disintegrating tablets
KR20100015568A (ko) * 2007-04-20 2010-02-12 닥터 레디스 레보러터리즈 리미티드 카페시타빈의 제조 방법
US8022216B2 (en) 2007-10-17 2011-09-20 Wyeth Llc Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
KR101013312B1 (ko) * 2007-11-19 2011-02-09 한미홀딩스 주식회사 카페시타빈의 제조방법 및 이에 사용되는 β-아노머가강화된 트리알킬카보네이트 화합물의 제조방법
AR064165A1 (es) * 2007-12-06 2009-03-18 Richmond Sa Com Ind Y Financie Un procedimiento para la preparacion de capecitabina e intermediarios utilizables en dicho procedimiento
WO2009088989A1 (en) * 2008-01-03 2009-07-16 Plus Chemicals, S.A. Process for the preparation of capecitabine
JP5749017B2 (ja) 2008-01-22 2015-07-15 ダウ アグロサイエンシィズ エルエルシー ５−フルオロピリミジン誘導体
SG191676A1 (en) 2008-06-17 2013-07-31 Wyeth Llc Antineoplastic combinations containing hki-272 and vinorelbine
CN109464445A (zh) * 2008-08-04 2019-03-15 惠氏有限责任公司 4-苯胺基-3-氰基喹啉和卡培他滨的抗肿瘤组合
WO2010061402A2 (en) * 2008-11-25 2010-06-03 Vishwanath Kannan An improved process for the preparation of capecitabine
EP2370414A4 (en) * 2008-12-02 2012-11-14 Reddys Lab Ltd Dr PREPARATION OF CAPECITABINE
CN101525362B (zh) * 2009-01-15 2011-05-11 浙江诚意药业有限公司 5’-脱氧-2’,3’-二乙酰-5-氟胞苷的制备方法
SG174382A1 (en) 2009-04-06 2011-11-28 Wyeth Llc Treatment regimen utilizing neratinib for breast cancer
JP2012533618A (ja) * 2009-07-23 2012-12-27 サイノファーム タイワン リミテッド フルオロシチジン誘導体の製造プロセス
CN102190695B (zh) * 2010-03-18 2013-12-18 齐鲁制药有限公司 5’-脱氧-2’，3’-二乙酰-5-氟胞苷的制备方法
CN101830952A (zh) * 2010-04-22 2010-09-15 上海柯林斯堡医药科技有限公司 2’,3’-o-二乙酰基-5’-脱氧-5-氟胞苷的制备方法
CN101830953A (zh) * 2010-05-26 2010-09-15 南京亚东启天药业有限公司 一种卡培他滨及其中间体的制备方法
WO2013063336A1 (en) * 2011-10-25 2013-05-02 Virginia Tech Intellectual Properties, Inc. Regioselectively substituted cellulose esters and efficient methods of preparing them
TWI560195B (en) * 2012-01-13 2016-12-01 Pharmaessentia Corp Novel synthesis of 5-deoxy-5'-fluorocytidine compounds
CN103570781B (zh) * 2012-07-02 2016-01-13 国药一心制药有限公司 一种卡培他滨的工业化制备方法
EP2883959A1 (en) 2013-12-13 2015-06-17 Plasmia Biotech, S.L. Enzymatic production of cytosinic nucleoside analogues
CN103897006A (zh) * 2013-12-18 2014-07-02 吉林修正药业新药开发有限公司 一种卡培他滨异构体的制备方法
US10858349B2 (en) * 2016-06-28 2020-12-08 Cellix Bio Private Limited Compositions and methods for the treatment of cancer
US11584733B2 (en) 2017-01-09 2023-02-21 Shuttle Pharmaceuticals, Inc. Selective histone deacetylase inhibitors for the treatment of human disease
ES2914123T3 (es) 2017-01-09 2022-06-07 Shuttle Pharmaceuticals Inc Inhibidores selectivos de la histona desacetilasa para el tratamiento de una enfermedad humana
CA3087565A1 (en) 2018-01-09 2019-07-18 Shuttle Pharmaceuticals, Inc. Selective histone deacetylase inhibitors for the treatment of human disease
MX2021000740A (es) * 2018-08-03 2021-03-26 Cellix Bio Private Ltd Composiciones y metodos para el tratamiento del cancer.
CN109651467A (zh) * 2019-01-15 2019-04-19 齐鲁天和惠世制药有限公司 一种卡培他滨杂质及其制备方法
CN111100172B (zh) * 2019-12-11 2023-03-17 中国科学院昆明植物研究所 一种胞嘧啶核苷衍生物及该衍生物制备卡培他滨药物的方法
WO2022049462A1 (en) * 2020-09-05 2022-03-10 Cellix Bio Private Limited Process for the preparation of derivatives of 5-fluoro pyrimidines used as anti cancer agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1327358C (en) * 1987-11-17 1994-03-01 Morio Fujiu Fluoro cytidine derivatives
ATE123289T1 (de) * 1988-12-07 1995-06-15 Yamasa Shoyu Kk Verbindungen von pyrimidin 2'-methylidin nukleosiden.
JPH0576898A (ja) * 1991-09-20 1993-03-30 Hitachi Kiden Kogyo Ltd スクリーン渣の破砕洗浄装置
FR2684997A1 (fr) 1991-12-12 1993-06-18 Centre Nat Rech Scient Derives de la 9-(beta-d-xylofurannosyl) adenine et de la 1-(beta-d-xylofurannosyl) cytosine, leur preparation et leur application en therapeutique.

Also Published As

Publication number Publication date
KR100343481B1 (ko) 2002-11-23
DE69303879T2 (de) 1997-01-30
JP3530218B2 (ja) 2004-05-24
JPH07300492A (ja) 1995-11-14
DK0602478T3 (da) 1996-09-30
CY2154B1 (en) 2002-08-23
CA2110335C (en) 2004-01-20
US5453497A (en) 1995-09-26
ATE140923T1 (de) 1996-08-15
CN1095070A (zh) 1994-11-16
CN1035675C (zh) 1997-08-20
TW254946B (cg-RX-API-DMAC10.html) 1995-08-21
JP2004123758A (ja) 2004-04-22
EP0602478A1 (en) 1994-06-22
RU2131879C1 (ru) 1999-06-20
JP4202274B2 (ja) 2008-12-24
DE69303879D1 (de) 1996-09-05
KR940014429A (ko) 1994-07-18
EP0602478B1 (en) 1996-07-31
CA2110335A1 (en) 1994-06-19

Similar Documents

Publication Publication Date Title
ES2093905T3 (es) Nuevo procedimiento para la obtencion de derivados de la n4-acil-5'-desoxi-5-fluorocitidina.
GEP20022656B (en) 2-(Purin-9-YL)-Tetrahydrofuran-3,4-Diol Derivatives
ES2124373T3 (es) Procedimiento para la preparacion de derivados del acido n-acil-n,n',n'-etilendiamintriacetico.
NO975387L (no) Fremgangsmåte for fremstilling av 3-haloalkyl-1H-pyrazoler
ES2038627T3 (es) Derivados del acido (met)-acrilico que contienen grupos uretano.
PT891371E (pt) Derivados 9-oxima-sililo da eritromicina a
AR004545A1 (es) Derivados de purin-6-ona, procedimientos para su preparacion, el uso de los mismos en la preparacion de medicamentos, medicamentos que los contieneny un procedimiento para preparar dichos medicamentos
MX9702666A (es) Nuevos peptidos con efectos inmunoreguladores.
DK256380A (da) Fremgangsmaade til fremstilling af 5!deoxy-5-fluoruridin
BG35042A3 (en) Method for preparing benzodiazepinic compounds
IT1101319B (it) Procedimento per trattare fanghi,risultanti dalla depurazione di gas,in modo da renderli utilizzabili
ES2132444T3 (es) Procedimiento para la produccion de fibras a partir de celulosa.
ES456574A1 (es) Procedimiento de obtencion de pentametil-carbamato de quer- cetina.
ES2193248T3 (es) Antraquinonas mono- y disulfosustituidas y su uso para el tratamiento de desordenes de la matriz osea.
SE7708780L (sv) Fluorsulfonyloxafluoroalkaner, deras derivat, fluorosulfonylolefiner, deras sampolymerer och forfarande for framstellning derav
LV10776A (lv) Tienopirana atvasinajumu iegusanas panemiens
DE3764559D1 (de) 4-benzyloxy-3-pyrrolin-2-on-1-yl-acetamid, dessen herstellung und verwendung.
BG41129A3 (en) Method for preparing acetamide derivatives
BG33436A3 (en) Method for obtaining of 4- dezacetyl- vinblastine- 3- spiro- 5"- oxazolidin- 2", 4"- dion
ES2068425T3 (es) Procedimiento para la preparacion de compuestos de 2-aril-5-(trifluormetil)pirrol insecticidas, acaricidas y nematicidas.
FR2392084A1 (fr) Nouveaux colorants azoiques, leur procede de preparation et leur utilisation
ES2068980T3 (es) Procedimiento para la preparacion de diterciobutoxidiacetoxisilano.
JPS51122620A (en) Process for producing cu-w fiber composite materials
SU703173A1 (ru) Самоустанавливающа с оправка дл волочени труб
ES2001452A6 (es) Procedimiento para la elaboracion y obtencion de una pomada o unguento

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 602478

Country of ref document: ES